Vudalimab
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Vudalimab for adenocarcinoma, clear cell | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vudalimab for endometrial neoplasms | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vudalimab for fallopian tube neoplasms | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vudalimab for prostatic neoplasms | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vudalimab for uterine cervical neoplasms | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |